Clinical Trials Directory

Trials / Completed

CompletedNCT03614520

Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Parc de Salut Mar · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims at studying in depth the absorption and metabolism of phenolic compounds of olive oil, wine and beer. This study is divided into 2 sub-studies in order to evaluate each one of the objectives.

Detailed description

The study is divided in two sub-studies to explore each objective. One the one hand, a group of people will drink olive oil, or wine, or both. This is done to see if combining these two drinks will improve the absorption and bioavailibility of phenolic compounds that they contain, promoting by synergy their antioxidant activity at a postprandial level. The main compounds studied are the Resveratrol (RSVT), the Hydroxytyrosol (HT), tyrosol (TIR) and their metabolits. One the other hand, an group of people will drink 3 different beers ( with 3 different degrees of alcohol), or wine, in order to study the absorption of TIR in relation to the alcohol degree. It also aims at assessing if the gas contained in beer contributes to TIR absorption. At different times after the administration of drinks, urine and blood samples will be collected.

Conditions

Interventions

TypeNameDescription
OTHERAdministration of olive oil25 mL of extra virgin olive oil
OTHERAdministration of red wine150 mL or Red Wine
OTHERCombination of red wine and olive oil150 mL of Red wine + 25 mL of Extra Virgin Olive oil will be administred at the same time
OTHERWaterMineral water will be given as placebo
OTHERDark beer250 mL of IPA beer (alcohol 8.5% vol)
OTHERLight Beer250 mL of blonde ale beer (alcohol 4,5% vol)
OTHERAlcohol free Beer250 mL of alcohol free beer (alcohol 0.0% vol)

Timeline

Start date
2018-07-09
Primary completion
2019-02-27
Completion
2019-02-27
First posted
2018-08-03
Last updated
2020-03-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03614520. Inclusion in this directory is not an endorsement.